Colorectal cancer [DS:H00020] Gastric cancer [DS:H00018]
Interaction
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01B ANTIMETABOLITES
L01BC Pyrimidine analogues
L01BC59 Trifluridine, combinations
D10526 Trifluridine and tipiracil hydrochloride <JP/US>
USP drug classification [BR:br08302]
Antineoplastics
Antineoplastics, Other
Tipiracil/ Trifluridine
D10526 Trifluridine and tipiracil hydrochloride
Therapeutic category of drugs in Japan [BR:br08301]
4 Agents affecting cellular function
42 Antineoplastics
429 Miscellaneous
4299 Others
D10526 Trifluridine and tipiracil hydrochloride
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D10526
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D10526
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D10526
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D10526